Coding sequence for aminoglycoside phosphotransferase I (aph-I)
Patents granted to Cetus Corporation (U.S. patent) & Chiron Corporation
(CA patent)
Actual granted independent claims
|
US
4784949* & CA 1337716 A1
|
|
(* Only Claim 1) Claim 1
A DNA sequence cassette encoding a dominant selectable marker effective in
prokaryotic and eukaryotic transformants which comprises:
a) an ATG start codon in reading frame with the codons of a modified
truncated aminoglycoside phosphotransferase-I (aph-I) gene, designated
herein mtaph-I, and b) at least one cassette-unique restriction
site upstream of and proximal to the ATG start codon, said mtaph-I
defined herein as the coding sequence for aph -I modified so as to
retain the amino acid sequence encoded by the aph-I gene, but to
eliminate any restriction site otherwise duplicated of said cassette-unique
restriction site, and truncated by deletion of codons encoding at least one
amino acid in positions 2 - 10 inclusive.
|
| Claim 4
A recombinant expression vector capable of conferring resistance to G418 on a
prokaryotic or eukaryotic transformant which vector comprises:
- an ATG start codon in reading frame with the codons of the mtaph-I
gene, all operably linked to appropriate control sequences functional in the
host harboring the vector,
said mtaph-I defined herein as the
coding sequence for aph-I modified so as to retain the amino acid
sequence encoded by the aph-I gene, but to eliminate any restriction
site otherwise duplicated of a cassette-unique restriction site, and
truncated by deletion of codons encoding at least one amino acid in positions 2
- 10 inclusive.
|
| Claim 17
An expression vector, operable in eukaryotic host cells, which comprises:
- mtaph-I coding sequences operably linked to control sequences
functional in the eucaryotic host,
said mtaph-I defined
herein as the coding sequence for aph-I modified so as to retain the
amino acid sequence encoded by the aph-I gene, but to eliminate any
restriction site otherwise duplicated of a cassette-unique restriction site,
and truncated by deletion of codons encoding at least one amino acid in
positions 2 - 10 inclusive.
|
| Claim 19
An expression vector, operable in eucaryotic host cells, which comprises:
- a coding sequence for a fusion protein operably linked to control sequences
functional in the eucaryotic host,
wherein the encoded fusion protein
comprises: a) a desired peptide as the N-terminal sequence and b)
mtaph-I as the C-terminal sequence, said mtaph-I defined
herein as the coding sequence for aph-I modified so as to retain the
amino acid sequence encoded by the aph-I gene, but to eliminate any
restriction site otherwise duplicated of a cassette-unique restriction site, and
truncated by deletion of codons encoding at least one amino acid in
positions 2 - 10 inclusive.
|
| Claim 30
A fusion protein which comprises:
a) an N-terminal sequence comprising the N-terminal amino acid sequence of a
desired protein and b) a C-terminal sequence comprising mtaph-I,
said mtaph-I defined herein as the coding sequence for aph-I
modified so as to retain the amino acid sequence encoded by the aph-I
gene, but to eliminate any restriction site otherwise duplicated of a
cassette-unique restriction site, and truncated by deletion of codons
encoding at least one amino acid in positions 2 - 10 inclusive.
|
| Claim 31
A fusion protein which comprises:
a) an N-terminal sequence comprising the N-terminal amino acid sequence of
B-isopropylmalate dehydrogenase and b) a C-terminal sequence comprising
mtaph-I, said mtaph-I defined herein as the coding sequence
for aph-I modified so as to retain the amino acid sequence encoded by
the aph-I gene, but to eliminate any restriction site otherwise
duplicated of a cassette-unique restriction site, and truncated by deletion
of codons encoding at least one amino acid in positions 2 - 10 inclusive.
|
| Claim 35
A fusion protein which comprises:
a) an N-terminal sequence comprising the N-terminal amino acid sequence of
yeast enolase and b) a C-terminal sequence comprising mtaph-I,
said mtaph-I defined herein as the coding sequence for aph-I
modified so as to retain the amino acid sequence encoded by the aph-I
gene, but to eliminate any restriction site otherwise duplicated of a
cassette-unique restriction site, and truncated by deletion of codons encoding
at least one amino acid in positions 2 - 10 inclusive.
|
| Claim 37
A method of purifying a fusion protein which method comprises:
- subjecting a fusion protein containing mtaph-I to an amino
glycoside containing support, said mtaph-I defined herein as the coding
sequence for aph -I modified so as to retain the amino acid sequence
encoded by the aph-I gene, but to eliminate any restriction site
otherwise duplicated of said cassette-unique restriction site, and truncated by
deletion of codons encoding at least one amino acid in positions 2 - 10
inclusive.
|
The information contained in this page was believed to be correct at the
time it was collated. New patents and patent applications, altered
status of patents, and case law may have resulted in changes in the
landscape. CAMBIA makes no warranty that it is correct or up to date at
this time and accepts no liability for any use that might be made of it.
Corrections or updates to the information are welcome. Please send an email to
info@bios.net.
There are no comments.